| Literature DB >> 31061813 |
Dominic Augustine1, Roopa S Rao1, Jayaraman Anbu2, K N Chidambara Murthy3.
Abstract
The current protocol of cancer management includes surgery, radiotherapy and chemotherapy. However, these modalities have significant adverse effects and affect the quality of life. Further intensification of treatment is hindered as maximal toxicity levels are reached impeding improvement. Hence researchers are in the quest for adjunctive naturally available therapies that can alter tumor proliferation without causing significant adverse reactions. The present study aims to explore the cytotoxic potential of earthworm coelomic fluid (ECF) of Eudrilus eugeniae (EE), Eisenia foetida (EF), and Perionyx excavatus (PE) on oral cancer cell line SCC-9. The effect of ECF on cell cycle analysis and mechanism of cell death have also been investigated. All experiments reported in this paper were performed as 3 replicates per experiment. The results indicated that ECF of EE, EF and PE have potent variable cytotoxic effect on SCC-9 cells demonstrated through LDH, clonogenic and comet assay. An effective cell cycle arrest was observed at the G2M phase of cell cycle with apoptotic induction that was observed through an Annexin V - FITC/PI assay. ECF of EE was found to be superior in its cytotoxic action closely followed by ECF of PE. The present findings provide evidence for the first time that ECF of EE, EF and PE have potent cytotoxic effect on oral cancer cells in vitro. They significantly induce G2M cell cycle arrest and promote apoptosis in SCC-9 cell line. Gene expression studies have been planned to ascertain the pathways of cell death.Entities:
Keywords: ATCC, American Type Culture Collection; Annexin V – FITC/PI; Apoptosis; CCD, charged coupled device; Cell cycle analysis; Cytotoxicity; DMEM, Dulbecco’s Modified Eagle Medium; DNA, deoxy ribose nucleic acid; ECF, earthworm coelomic fluid; EE, Eudrilus eugeniae; EF, Eisenia foetida; Earthworm coelomic fluid; Eisenia foetida; Eudrilus eugeniae; FBS, fetal bovine serum; FITC, fluorescein isothiocyanate; HEPES, 4-2-hydroxyethyl)-1-piperazineethanesulfonic acid; LDH, lactate dehydrogenase; LMPA, low melting point agarose; MEM, Minimal Essential Medium; NAE’s, naturally available extracts; NMA, normal melting agarose; PE, Perionyx excavatus; PS, phosphatidylserine; Perionyx excavatus; SCC, squamous cell carcinoma; SCC-9 cell line
Year: 2019 PMID: 31061813 PMCID: PMC6488712 DOI: 10.1016/j.toxrep.2019.04.005
Source DB: PubMed Journal: Toxicol Rep ISSN: 2214-7500
Summary of LDH enzyme release activity for samples ECF of EE, EF and PE in SCC-9 cells. ECF of EE induced maximum LDH activity in SCC-9 cells followed by ECF of PE and EF.
| Test Sample | Conc. (μg/ml) | Absorbance | LDH activity (U/L) |
|---|---|---|---|
| ECF of EE | 0.0 | 0.2015 | 3230.05 |
| 2.5 | 0.2135 | 3422.41 | |
| 5 | 0.2251 | 3608.35 | |
| 10 | 0.2315 | 3710.95 | |
| 20 | 0.2437 | 3906.51 | |
| 40 | 0.2849 | 4566.95 | |
| 80 | 0.3094 | 4959.68 | |
| ECF of EF | 0.0 | 0.1496 | 2398.09 |
| 2.5 | 0.1511 | 2422.13 | |
| 5 | 0.1645 | 2636.94 | |
| 10 | 0.1898 | 3042.49 | |
| 20 | 0.2099 | 3364.70 | |
| 40 | 0.2268 | 3635.60 | |
| 80 | 0.2496 | 4001.09 | |
| ECF of PE | 0.0 | 0.1896 | 3039.29 |
| 2.5 | 0.2011 | 3223.63 | |
| 5 | 0.2145 | 3438.44 | |
| 10 | 0.2398 | 3843.99 | |
| 20 | 0.2412 | 3866.44 | |
| 40 | 0.2638 | 4228.71 | |
| 80 | 0.2846 | 4562.14 |
Fig. 1Bar graph depicting the dose depending LDH enzyme generation of ECF on SCC-9 cells A. LDH activity of ECF of EE. B. LDH activity of ECF of EF. C. LDH activity of ECF of PE. D. Summary of LDH activity, ECF of EE shows maximum LDH activity of 4959 U/L at 80 μg/ml, followed by ECF of PE and EF.
Clonogenic assay colony count table with plating efficiency and surviving fraction values. ECF of EE was found to be superior to ECF of PE and EF.
| Test Sample | Conc. (μg/ml) | Colony Count | Plating Efficiency | Surviving Fraction |
|---|---|---|---|---|
| Control | 0 | 56 | 1.12 | 100.00 |
| ECF of EE | 40 | 14 | 0.28 | 25.00 |
| 80 | 1 | 0.02 | 1.79 | |
| ECF of EF | 40 | 37 | 0.74 | 66.07 |
| 80 | 9 | 0.18 | 16.07 | |
| ECF od PE | 40 | 18 | 0.36 | 32.14 |
| 80 | 0 | 0 | 0.00 |
Fig. 2Clonogenic assay performed in 35 mm dish, with clones produced by SCC-9 tumor cells. A. Assay procedure and micro pipetting B. Incubation in CO2 incubator at 37 °C. C. Untreated SCC-9 control cells. D. Colonies produced after treatment with ECF of EE – 40 μg/ml. E. Colonies produced after treatment with ECF of EE – 80 μg/ml. F. Colonies produced after treatment with ECF of EF - 40 μg/ml. G. Colonies produced after treatment with ECF of EF – 80 μg/ml. H. Colonies produced after treatment with ECF of PE – 40 μg/ml. I. Colonies produced after treatment with ECF of PE – 80 μg/ml. ECF of EE and PE were most efficient in colony formation inhibition.
Summary of olive moments recorded in test samples. Values are shown as mean ± SD of 3 replicates per experiment.
| Test Samples | Olive Moments (Mean ± SD) |
|---|---|
| Control | 1.26 ± 0.30 |
| Positive Control H2O2 (100 μM) | 8.28 ± 1.25 |
| Sample 1-(40 μg/ml) – ECF of EE | 2.56 ± 0.49 |
| Sample 1-(80 μg/ml) – ECF of EE | 3.58 ± 0.54 |
| Sample 2-(40 μg/ml) – ECF of EF | 3.65 ± 0.76 |
| Sample 2-(80 μg/ml) – ECF of EF | 5.09 ± 0.29 |
| Sample 3-(40 μg/ml) – ECF of PE | 4.79 ± 0.41 |
| Sample 3-(80 μg/ml) – ECF of PE | 6.19 ± 0.23 |
Fig. 3Florescence images of comets observed for different test samples. A. Comet images for control (saline) on SCC-9 cells. B. Comet images for positive control H2O2 at 100 μM. C. Comet images for ECF of EE – 40 μg/ml. D. Comet images for ECF of EE – 80 μg/ml. E. Comet images for ECF of EF – 40 μg/ml. F. Comet images for ECF of EF – 80 μg/ml. G. Comet images for ECF of PE – 40 μg/ml. H. Comet images for ECF of PE – 80 μg/ml. I. Graphical representation of DNA damage expressed in olive moments in Test samples J. Statistical evaluation of olive moments by Dunnett’s multiple comparison test. ECF of PE showed maximum DNA strand breakage capacity.
Comparison of G2M phase cell cycle arrest of ECF of EE, EF and PE at 40 μg/ml and 80 μg/ml on SCC-9 cells.
| Sl No | Test Sample | G2M Cell Cycle Arrest % | |
|---|---|---|---|
| 1. | Control Cells | – | 3.530 |
| 2. | ECF of EE | 40 μg/ml | 70.77 |
| 80 μg/ml | 85.13 | ||
| 3. | ECF of EF | 40 μg/ml | 41.44 |
| 80 μg/ml | 57.51 | ||
| 4. | ECF of PE | 40 μg/ml | 80.88 |
| 80 μg/ml | 91.46 | ||
Fig. 4Flowcytometry images for Cell Cycle Analysis. A. Flow Cytometry plot of SCC-9 cells treated with control. B. Flowcytometry plot for G2M arrest induced by ECF of EE – 40 μg/ml. C. Flowcytometry plot for G2M arrest induced by ECF of EF – 40 μg/ml. D. Flowcytometry plot for G2M arrest induced by ECF of PE – 40 μg/ml. ECF of PE exhibited highest arrest percentage of 80.88% at concentrations of 40 μg/ml, followed by ECF of EE and EF.
Fig. 5Flowcytometry images for Cell Cycle Analysis. A. Flow Cytometry plot of SCC-9 cells treated with control. B. Flowcytometry plot for G2M arrest induced by ECF of EE – 80 μg/ml. C. Flowcytometry plot for G2M arrest induced by ECF of EF – 80 μg/ml. D. Flowcytometry plot for G2M arrest induced by ECF of PE – 80 μg/ml. ECF of PE exhibited highest arrest percentage of 91.46% at concentrations of 80 μg/ml, followed by ECF of EE and EF.
Pairwise Kruskal Wallis test comparing the G2M cell cycle arrest between the species at 40 μg/ml and 80 μg/ml.
| Samples (at 40 μg/ml) | Test Statistic | Sig. | Adj. Sig |
|---|---|---|---|
| EE-PE | 5.333 | 0.021 | 0.063 |
| EE-EF | 10.500 | 0.001 | 0.004 |
| PE-EF | 10.500 | 0.001 | 0.004 |
Fig. 6Flowcytometry plots for Annexin V-FITC/PI assay (at 40 μg/ml). A. Flowcytometry plot for SCC-9 untreated control cells. B. Flowcytometry plot for SCC-9 cells treated with ECF of EE (40 μg/ml). C. Flowcytometry plot for SCC-9 cells treated with ECF of EF (40 μg/ml). D. Flowcytometry plot for SCC-9 cells treated with ECF of PE (40 μg/ml). E. Comparison of apoptotic cell percentage of ECF of EE, EF and PE at 40 μg/ml.
Fig. 7Flowcytometry plots for Annexin V-FITC/PI assay (at 80 μg/ml). A. Flowcytometry plot for SCC-9 untreated control cells. B. Flowcytometry plot for SCC-9 cells treated with ECF of EE (80 μg/ml). C. Flowcytometry plot for SCC-9 cells treated with ECF of EF (80 μg/ml). D. Flowcytometry plot for SCC-9 cells treated with ECF of PE (80 μg/ml). E. Comparison of apoptotic cell percentage of ECF of EE, EF and PE at 80 μg/ml.
Pairwise Kruskal Wallis test comparing the early and late apoptosis between the species.
| Samples (Early Apoptois) | Test Statistic | Std Error | Std Test Statistic | Sig. | Adj. Sig |
|---|---|---|---|---|---|
| EF-PE | −6.000 | 3.073 | −1.953 | 0.051 | 0.153 |
| EF-EE | 12.000 | 3.073 | 3.905 | 0.000 | 0.000 |
| PE-EE | 6.000 | 3.073 | 1.953 | 0.051 | 0.153 |
Fig. 8Fluorescent images of SCC-9 cells dual staining with AO/EB. A & B. Control cells stained with AO/EB. C. SCC-9 cells treated with ECF of EE at 40 μg/ml has early apoptotic cells. D. SCC-9 cells treated with ECF of EE at 80 μg/ml has early and late apoptotic cells. E. SCC-9 cells treated with ECF of EF at 40 μg/ml has late apoptotic and necrotic cells. F. SCC-9 cells treated with ECF of EF at 80 μg/ml has necrotic cells. G. SCC-9 cells treated with ECF of PE at 40 μg/ml has early apoptotic, late apoptotic and necrotic cells. H. SCC-9 cells treated with ECF of PE at 80 μg/ml has necrotic cells. ECF of EE had more apoptotic cell morphology compared to ECF of EF and PE.